Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data
Z Xue, Y Zhou, C Wu, J Lin, X Liu, W Zhu - Heart Failure Reviews, 2020 - Springer
The role of non-vitamin K antagonist oral anticoagulants (NOACs) in stroke prevention
remains unclear in Asian patients with atrial fibrillation (AF). Therefore, we performed a meta …
remains unclear in Asian patients with atrial fibrillation (AF). Therefore, we performed a meta …
Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation
YH Chan, TF Chao, SW Chen, HF Lee, YH Yeh… - Heart rhythm, 2020 - Elsevier
Background Off-label dosing non–vitamin K antagonist oral anticoagulants (NOACs) are
commonly prescribed for Asian patients with atrial fibrillation (AF). Objective The purpose of …
commonly prescribed for Asian patients with atrial fibrillation (AF). Objective The purpose of …
The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared …
Background Although randomized trials provide a high level of evidence regarding the
efficacy of non-vitamin K oral anticoagulants (NOACs), the results of such trials may differ …
efficacy of non-vitamin K oral anticoagulants (NOACs), the results of such trials may differ …
Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
L Friberg, J Oldgren - Open Heart, 2017 - openheart.bmj.com
Aims Non-vitamin K antagonist oral anticoagulants (NOACs) were in pivotal randomised
controlled trials at least non-inferior to warfarin for stroke prevention in atrial fibrillation, but …
controlled trials at least non-inferior to warfarin for stroke prevention in atrial fibrillation, but …
Use of non‐vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic
Background Non‐vitamin K antagonist oral anticoagulants (NOAC s) are broadly preferable
to vitamin K antagonists (VKA s) for stroke prevention in non‐valvular atrial fibrillation (AF) …
to vitamin K antagonists (VKA s) for stroke prevention in non‐valvular atrial fibrillation (AF) …
Efficacy and safety of the use of non–vitamin K antagonist oral anticoagulants in patients with nonvalvular atrial fibrillation and concomitant aspirin therapy: a meta …
N Bennaghmouch, AJWM de Veer, K Bode… - Circulation, 2018 - Am Heart Assoc
Background: Current guidelines recommend non–vitamin K antagonist oral anticoagulants
(NOACs) as the first-choice therapy in patients with nonvalvular atrial fibrillation because …
(NOACs) as the first-choice therapy in patients with nonvalvular atrial fibrillation because …
[HTML][HTML] Impact of double‐blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta‐analysis
JC Lega, P Mismetti, M Cucherat, T Fassier… - Journal of Thrombosis …, 2013 - Elsevier
Background The prospective, randomized, open, blinded endpoint evaluation (PROBE)
design has been proposed as a valid alternative to the double‐blind (DB) design for trials …
design has been proposed as a valid alternative to the double‐blind (DB) design for trials …
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation with Coronary or Peripheral Artery Disease A Meta-Analysis
H Zhang, Z Xue, D Yi, X Li, Y Tan, J Li - International Heart Journal, 2020 - jstage.jst.go.jp
The efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in atrial
fibrillation (AF) with coronary or peripheral artery disease (CAD or PAD) remain largely …
fibrillation (AF) with coronary or peripheral artery disease (CAD or PAD) remain largely …
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach
P Verdecchia, F Angeli, C Bartolini… - Expert Opinion on …, 2015 - Taylor & Francis
Introduction: Choosing between different non-vitamin K antagonist oral anticoagulants
(NOACs) in non-valvular atrial fibrillation (NVAF) is difficult due to the absence of head to …
(NOACs) in non-valvular atrial fibrillation (NVAF) is difficult due to the absence of head to …